A study in healthy male subjects to understand how Savolitinib behaves inside the body (pharmacokinetics) when administered alone and in combination with famotidine

Trial Identifier: D5084C00005
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04179071
Start Date: December 2019
Primary Completion Date: March 2020
Study Completion Date: March 2020
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United States of America, MD Baltimore, MD, United States of America, 21225